Nifty

:

24213.30

Sensex

:

79476.63

217.95 (0.91%)
694.39 (0.88%)

Login

Nifty
Sensex

:
:

24213.30
79476.63

217.95 (0.91%)
694.39 (0.88%)

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 506197 | NSE: BLISSGVS

Watchlist

NSE BSE

113.73

05-Jul-2024

Open
High
Low
Previous Close

112.00
115.80
111.10
113.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1203586
1372.01
149.60
92.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,294.16
20.61
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,157.61
0.41%
1.29

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.58
2.25
1.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.72
3.85
4.71

PAT CAGR (%)

10 Years
5 Years
3 Years

2.33
-4.95
71.19

P:E (Median)

8 Years
5 Years
3 Years

17.35
15.32
15.67

P:BV (Average)

8 Years
5 Years
3 Years

2.02
1.38
1.10

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.75
7.46
6.09

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 182.65 171.31 6.62% 148.96 108.99 36.67% 163.82 143.42 14.22% 161.33 168.79 -4.42%
Expenses 157.27 129.01 21.91% 122.22 97.94 24.79% 138.67 132.51 4.65% 132.68 135.33 -1.96%
EBITDA 25.38 42.31 -40.01% 26.74 11.05 141.99% 25.15 10.91 130.52% 28.66 33.46 -14.35%
EBIDTM 13.90% 24.70% 17.95% 10.14% 15.35% 7.61% 17.76% 19.82%
Other Income 8.35 10.61 -21.30% 6.84 6.53 4.75% 8.46 6.48 30.56% 7.90 11.42 -30.82%
Interest 3.45 1.18 192.37% 1.17 1.31 -10.69% 1.53 4.97 -69.22% 1.79 1.20 49.17%
Depreciation 6.40 5.68 12.68% 6.26 5.36 16.79% 6.23 3.97 56.93% 6.25 3.79 64.91%
PBT 23.89 46.07 -48.14% 26.15 10.90 139.91% -15.23 8.44 - 28.52 39.89 -28.50%
Tax 6.85 12.18 -43.76% 6.73 3.41 97.36% -3.77 2.34 - 7.80 10.61 -26.48%
PAT 17.04 33.89 -49.72% 19.42 7.50 158.93% -11.46 6.10 - 20.72 29.28 -29.23%
PATM 9.33% 19.78% 13.04% 6.88% -7.00% 4.26% 12.84% 17.35%
EPS 1.62 3.22 -49.69% 1.85 0.71 160.56% -1.09 0.58 - 1.97 2.79 -29.39%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 217.68 211.88 2.74% 183.64 159.52 15.12% 198.13 184.78 7.22% 200.72 205.72 -2.43%
Expenses 176.20 157.51 11.87% 149.31 135.31 10.35% 169.78 178.54 -4.91% 157.03 158.03 -0.63%
EBITDA 41.48 54.37 -23.71% 34.33 24.21 41.80% 28.35 6.24 354.33% 43.69 47.69 -8.39%
EBIDTM 19.05% 25.66% 18.69% 15.18% 14.31% 3.38% 21.77% 23.18%
Other Income 5.04 12.60 -60.00% 4.12 5.11 -19.37% 5.60 2.98 87.92% 5.42 5.65 -4.07%
Interest 3.83 1.45 164.14% 1.53 1.49 2.68% 1.85 5.08 -63.58% 2.12 1.26 68.25%
Depreciation 6.98 6.39 9.23% 6.85 6.19 10.66% 6.85 4.88 40.37% 6.95 4.64 49.78%
PBT 35.71 59.13 -39.61% 30.07 21.64 38.96% -3.95 -0.75 - 40.04 47.43 -15.58%
Tax 10.01 16.09 -37.79% 7.97 7.27 9.63% 0.97 -4.22 - 10.97 17.64 -37.81%
PAT 25.69 43.04 -40.31% 22.11 14.37 53.86% -4.91 3.47 - 29.07 29.79 -2.42%
PATM 11.80% 20.32% 12.04% 9.01% -2.48% 1.88% 14.48% 14.48%
EPS 2.31 4.05 -42.96% 1.97 1.41 39.72% -0.87 0.32 - 2.64 2.68 -1.49%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 656.76 605.46 598.34 636.36 465.51 441.95 426.59 297.89 348.02 326.38 313.02 Net Sales Growth 10.84% 1.19% -5.97% 36.70% 5.33% 3.60% 43.20% -14.40% 6.63% 4.27% Cost Of Goods Sold 337.14 299.47 314.90 343.94 253.30 236.73 225.15 145.81 167.21 114.36 116.45 Gross Profit 319.62 305.99 283.44 292.41 212.21 205.23 201.44 152.08 180.80 212.03 196.57 GP Margin 48.67% 50.54% 47.37% 45.95% 45.59% 46.44% 47.22% 51.05% 51.95% 64.96% 62.80% Total Expenditure 550.84 499.94 508.18 527.16 374.05 341.78 333.49 209.43 247.49 229.87 226.83 Power & Fuel Cost - 8.81 5.80 7.09 6.99 4.70 3.57 2.59 2.73 2.82 2.69 % Of Sales - 1.46% 0.97% 1.11% 1.50% 1.06% 0.84% 0.87% 0.78% 0.86% 0.86% Employee Cost - 82.59 72.54 65.06 58.61 44.02 33.85 26.29 25.03 21.89 17.36 % Of Sales - 13.64% 12.12% 10.22% 12.59% 9.96% 7.94% 8.83% 7.19% 6.71% 5.55% Manufacturing Exp. - 17.25 11.09 10.91 7.13 5.97 4.24 3.64 3.31 23.87 27.77 % Of Sales - 2.85% 1.85% 1.71% 1.53% 1.35% 0.99% 1.22% 0.95% 7.31% 8.87% General & Admin Exp. - 11.61 10.88 12.00 8.70 10.33 13.71 11.11 11.73 17.31 18.20 % Of Sales - 1.92% 1.82% 1.89% 1.87% 2.34% 3.21% 3.73% 3.37% 5.30% 5.81% Selling & Distn. Exp. - 55.12 56.50 55.70 28.56 26.16 31.07 14.77 26.29 35.26 31.20 % Of Sales - 9.10% 9.44% 8.75% 6.14% 5.92% 7.28% 4.96% 7.55% 10.80% 9.97% Miscellaneous Exp. - 25.09 36.48 32.45 10.76 13.88 21.91 5.22 11.18 14.35 31.20 % Of Sales - 4.14% 6.10% 5.10% 2.31% 3.14% 5.14% 1.75% 3.21% 4.40% 4.20% EBITDA 105.93 105.52 90.16 109.20 91.46 100.17 93.10 88.46 100.53 96.51 86.19 EBITDA Margin 16.13% 17.43% 15.07% 17.16% 19.65% 22.67% 21.82% 29.70% 28.89% 29.57% 27.53% Other Income 31.55 35.15 50.77 32.63 19.41 37.00 35.81 10.99 9.08 23.08 21.35 Interest 7.94 5.81 10.06 4.32 5.92 6.62 3.15 6.95 9.07 13.53 11.21 Depreciation 25.14 23.52 15.17 13.85 13.76 8.83 5.75 5.67 5.62 5.85 5.08 PBT 63.33 111.34 115.69 123.66 91.19 121.71 120.01 86.84 94.91 100.21 91.25 Tax 17.61 19.61 30.21 33.74 23.69 29.38 45.58 29.82 35.77 34.60 31.24 Tax Rate 27.81% 27.91% 26.11% 26.69% 25.98% 24.14% 37.98% 34.34% 37.69% 34.53% 34.24% PAT 45.72 50.64 85.48 92.66 67.50 92.33 74.43 57.01 59.13 65.61 60.02 PAT before Minority Interest 45.72 50.64 85.48 92.66 67.50 92.33 74.43 57.01 59.13 65.61 60.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.96% 8.36% 14.29% 14.56% 14.50% 20.89% 17.45% 19.14% 16.99% 20.10% 19.17% PAT Growth -40.45% -40.76% -7.75% 37.27% -26.89% 24.05% 30.56% -3.59% -9.88% 9.31% EPS 4.35 4.82 8.13 8.82 6.42 8.78 7.08 5.42 5.63 6.24 5.71

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 800.17 770.24 751.59 747.45 577.21 689.31 898.57 814.64 798.44 546.89 407.13 Net Sales Growth 5.02% 2.48% 0.55% 29.49% -16.26% -23.29% 10.30% 2.03% 46.00% 34.33% Cost Of Goods Sold 398.02 382.11 401.32 390.98 329.71 439.97 612.26 391.13 358.93 237.18 152.77 Gross Profit 402.15 388.13 350.26 356.47 247.49 249.34 286.31 423.52 439.51 309.72 254.37 GP Margin 50.26% 50.39% 46.60% 47.69% 42.88% 36.17% 31.86% 51.99% 55.05% 56.63% 62.48% Total Expenditure 652.32 621.27 634.26 629.11 470.56 565.99 740.93 617.50 595.70 391.17 303.70 Power & Fuel Cost - 10.43 7.13 8.25 8.14 5.88 4.76 5.49 5.58 4.72 4.36 % Of Sales - 1.35% 0.95% 1.10% 1.41% 0.85% 0.53% 0.67% 0.70% 0.86% 1.07% Employee Cost - 95.58 86.17 76.15 68.09 53.69 42.32 69.23 61.35 33.74 29.43 % Of Sales - 12.41% 11.47% 10.19% 11.80% 7.79% 4.71% 8.50% 7.68% 6.17% 7.23% Manufacturing Exp. - 18.59 12.24 12.09 7.83 7.07 4.95 4.88 5.39 25.65 29.98 % Of Sales - 2.41% 1.63% 1.62% 1.36% 1.03% 0.55% 0.60% 0.68% 4.69% 7.36% General & Admin Exp. - 17.48 16.50 15.03 12.03 13.27 17.05 39.48 36.36 24.68 17.07 % Of Sales - 2.27% 2.20% 2.01% 2.08% 1.93% 1.90% 4.85% 4.55% 4.51% 4.19% Selling & Distn. Exp. - 68.41 63.95 67.18 31.35 28.83 34.72 62.09 92.46 42.51 47.05 % Of Sales - 8.88% 8.51% 8.99% 5.43% 4.18% 3.86% 7.62% 11.58% 7.77% 11.56% Miscellaneous Exp. - 28.67 46.96 59.43 13.40 17.28 24.86 45.21 35.63 22.71 47.05 % Of Sales - 3.72% 6.25% 7.95% 2.32% 2.51% 2.77% 5.55% 4.46% 4.15% 5.66% EBITDA 147.85 148.97 117.33 118.34 106.65 123.32 157.64 197.14 202.74 155.72 103.43 EBITDA Margin 18.48% 19.34% 15.61% 15.83% 18.48% 17.89% 17.54% 24.20% 25.39% 28.47% 25.40% Other Income 20.18 30.39 17.79 31.49 21.95 39.19 37.63 26.54 12.51 24.35 20.29 Interest 9.33 6.91 10.36 4.74 7.24 7.57 4.41 22.80 19.69 18.61 16.41 Depreciation 27.63 26.38 18.67 17.33 17.23 12.59 8.94 21.38 20.14 13.26 11.30 PBT 101.87 146.07 106.07 127.76 104.13 142.35 181.92 179.49 175.40 148.19 96.02 Tax 29.92 35.29 29.34 31.04 30.16 33.71 55.25 56.63 62.72 48.05 34.63 Tax Rate 29.37% 30.20% 27.66% 57.30% 28.96% 26.14% 30.37% 38.98% 35.76% 32.42% 36.07% PAT 71.96 75.46 70.85 15.04 68.49 97.26 123.72 58.78 82.04 82.49 59.91 PAT before Minority Interest 63.43 81.58 76.73 23.13 73.97 95.25 126.66 88.66 112.68 100.15 61.39 Minority Interest -8.53 -6.12 -5.88 -8.09 -5.48 2.01 -2.94 -29.88 -30.64 -17.66 -1.48 PAT Margin 8.99% 9.80% 9.43% 2.01% 11.87% 14.11% 13.77% 7.22% 10.28% 15.08% 14.72% PAT Growth -20.64% 6.51% 371.08% -78.04% -29.58% -21.39% 110.48% -28.35% -0.55% 37.69% EPS 6.85 7.18 6.74 1.43 6.52 9.25 11.77 5.59 7.81 7.85 5.70

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 988.44 937.00 851.43 755.65 682.94 603.27 541.42 491.64 432.07 368.19 Share Capital 10.47 10.42 10.37 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 970.25 917.69 831.12 735.50 672.63 592.96 531.11 481.33 421.76 357.87 Non-Current Liabilities 42.69 49.34 35.71 43.87 46.66 40.60 15.73 22.84 21.78 38.76 Secured Loans 35.10 40.69 23.22 32.49 35.55 30.53 5.55 12.47 11.84 30.21 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.47 2.61 1.07 2.50 2.44 1.75 1.91 1.81 1.67 1.40 Current Liabilities 117.31 153.36 192.83 146.11 125.50 91.98 136.85 151.82 243.28 148.05 Trade Payables 54.47 75.87 84.21 66.78 55.95 30.87 35.34 63.80 35.06 50.47 Other Current Liabilities 51.57 50.72 62.46 42.36 32.75 23.47 11.81 11.84 29.10 39.13 Short Term Borrowings 10.74 25.02 41.47 35.38 35.94 36.64 82.53 61.50 49.95 28.38 Short Term Provisions 0.54 1.74 4.69 1.59 0.87 1.01 7.18 14.68 129.17 30.08 Total Liabilities 1,148.44 1,139.70 1,079.97 945.63 855.10 735.85 694.00 666.30 697.13 555.00 Net Block 329.95 324.82 224.31 174.10 178.86 78.32 72.48 75.34 79.09 81.50 Gross Block 413.45 385.02 269.54 210.93 202.33 93.44 83.40 80.85 122.93 119.59 Accumulated Depreciation 83.50 60.21 45.22 36.84 23.47 15.12 10.92 5.51 43.84 38.08 Non Current Assets 375.46 410.04 288.22 268.98 212.46 157.95 117.72 111.50 212.12 202.08 Capital Work in Progress 7.83 2.80 22.15 2.39 0.00 42.91 0.47 1.98 1.98 0.00 Non Current Investment 18.69 18.26 18.26 18.99 19.00 19.01 19.17 21.54 20.59 19.23 Long Term Loans & Adv. 15.80 17.18 22.44 11.35 13.36 17.38 25.31 12.23 110.45 101.35 Other Non Current Assets 2.50 46.30 0.37 62.15 1.24 0.33 0.29 0.42 0.00 0.00 Current Assets 772.98 729.65 791.74 676.64 642.65 577.90 576.29 554.80 485.02 352.49 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 89.45 74.15 90.11 83.68 60.57 54.84 39.80 28.06 21.95 22.52 Sundry Debtors 399.51 399.06 408.82 348.68 404.91 342.09 282.54 239.41 250.58 210.61 Cash & Bank 169.32 84.61 149.48 119.52 86.62 93.29 70.29 83.57 56.90 47.37 Other Current Assets 114.70 14.15 16.77 23.28 90.55 87.68 183.65 203.76 155.59 71.99 Short Term Loans & Adv. 88.96 157.68 126.55 101.48 74.25 62.40 143.27 173.39 136.36 50.95 Net Current Assets 655.67 576.30 598.91 530.54 517.15 485.92 439.44 402.98 241.74 204.43 Total Assets 1,148.44 1,139.69 1,079.96 945.62 855.11 735.85 694.01 666.30 697.14 555.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 967.19 883.90 818.70 808.25 735.61 646.00 536.24 486.62 412.62 337.08 Share Capital 10.47 10.42 10.37 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 949.00 864.59 798.40 788.10 725.30 635.68 525.92 476.31 402.31 326.77 Non-Current Liabilities 51.06 42.84 29.20 45.24 46.32 37.99 12.92 32.81 49.55 67.52 Secured Loans 35.59 40.69 23.22 32.60 37.24 32.54 5.92 25.58 29.62 55.03 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.62 2.23 Long Term Provisions 2.54 2.69 1.07 2.50 2.44 1.75 1.91 2.05 1.81 1.40 Current Liabilities 159.82 193.26 233.09 203.64 230.53 207.03 299.40 437.09 378.97 242.68 Trade Payables 60.97 86.39 92.61 74.22 89.92 78.88 58.43 98.25 108.49 80.33 Other Current Liabilities 64.87 58.20 67.85 53.69 57.21 50.24 124.46 99.93 52.76 70.30 Short Term Borrowings 32.12 46.01 60.70 65.04 66.39 64.30 105.66 187.47 62.12 61.04 Short Term Provisions 1.87 2.66 11.93 10.69 17.01 13.61 10.85 51.45 155.60 31.00 Total Liabilities 1,213.86 1,153.53 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 874.24 662.17 Net Block 369.37 378.05 280.76 233.72 240.97 144.97 136.48 303.86 225.25 234.38 Gross Block 467.78 458.74 343.41 285.10 276.07 169.89 157.47 326.83 300.74 293.82 Accumulated Depreciation 98.41 80.69 62.65 51.38 35.10 24.92 20.99 22.97 75.48 59.44 Non Current Assets 402.25 456.15 331.89 311.59 257.48 211.39 170.25 456.97 291.23 244.66 Capital Work in Progress 7.83 2.80 22.15 2.39 0.00 46.74 0.47 4.03 9.10 0.00 Non Current Investment 3.61 2.84 2.39 0.70 0.72 0.72 6.30 1.05 0.11 0.01 Long Term Loans & Adv. 16.25 17.62 24.42 12.63 14.56 18.63 26.72 11.45 56.77 10.27 Other Non Current Assets 4.50 54.16 1.47 62.15 1.24 0.33 0.29 136.58 0.00 0.00 Current Assets 811.62 697.37 776.86 765.20 769.74 693.49 689.79 565.93 583.00 417.08 Current Investments 0.56 4.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 118.45 103.06 123.94 98.93 74.14 77.37 59.03 49.30 38.67 33.70 Sundry Debtors 404.35 385.17 392.75 463.82 547.91 460.73 298.48 254.45 300.93 247.47 Cash & Bank 215.62 102.99 177.53 144.55 103.32 106.63 88.86 150.50 78.18 57.29 Other Current Assets 72.66 6.63 14.12 17.55 44.37 48.76 243.41 111.68 165.22 78.62 Short Term Loans & Adv. 55.65 94.56 68.52 40.35 28.24 22.55 146.30 78.44 149.92 60.69 Net Current Assets 651.80 504.11 543.77 561.56 539.21 486.47 390.39 128.84 204.03 174.40 Total Assets 1,213.87 1,153.52 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 874.23 662.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 125.92 43.81 114.05 66.97 63.22 48.29 22.67 38.48 59.61 15.35 PBT 111.34 115.69 123.66 91.19 121.71 120.01 86.84 94.91 100.21 91.25 Adjustment 44.27 41.42 35.10 41.14 3.43 3.36 0.77 28.12 7.21 14.91 Changes in Working Capital -0.35 -75.58 -14.23 -42.64 -30.07 -25.53 -29.06 -47.37 -27.78 -50.62 Cash after chg. in Working capital 155.26 81.53 144.52 89.69 95.08 97.84 58.54 75.65 79.64 55.55 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -29.34 -37.72 -30.47 -22.72 -31.86 -49.55 -35.87 -37.17 -20.03 -40.19 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -109.59 -12.97 -92.28 -61.62 -60.14 -68.04 16.36 -29.34 -10.29 -21.49 Net Fixed Assets -33.46 -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 -5.32 -28.78 Net Investments -0.43 0.00 0.73 0.01 0.01 0.16 2.37 -0.95 -1.36 0.00 Others -75.70 83.16 -14.64 -50.64 5.83 -15.72 15.03 -70.47 -3.61 7.29 Cash from Financing Activity -20.76 -26.05 -12.62 -11.67 -5.83 9.05 -21.91 -14.77 -35.34 -31.23 Net Cash Inflow / Outflow -4.43 4.79 9.14 -6.33 -2.75 -10.70 17.12 -5.63 13.98 -37.37 Opening Cash & Equivalents 18.60 13.82 4.67 11.00 13.75 24.45 7.33 12.95 3.40 38.70 Closing Cash & Equivalent 14.17 18.60 13.82 4.67 11.00 13.75 24.45 7.33 12.95 3.40

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 152.45 34.31 135.48 63.97 46.70 39.95 17.64 289.47 112.95 48.94 PBT 146.07 106.07 127.76 104.13 128.97 181.91 179.49 175.40 148.19 96.02 Adjustment 38.19 57.92 -31.71 46.29 26.85 -10.97 17.55 36.24 18.18 22.48 Changes in Working Capital 3.04 -85.12 73.37 -57.89 -70.32 -183.07 -140.80 113.48 -8.33 -60.94 Cash after chg. in Working capital 187.30 78.87 169.42 92.53 85.49 -12.13 56.24 325.13 158.05 57.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -34.85 -44.56 -33.94 -28.56 -38.79 52.08 -38.61 -35.66 -45.10 -8.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -132.82 -7.75 -92.98 -46.99 -47.89 -73.52 50.24 -231.25 -49.84 -38.98 Net Fixed Assets -33.46 -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 -5.32 -28.78 Net Investments -0.43 0.00 0.73 0.01 0.01 0.16 2.37 -0.95 -1.36 0.00 Others -98.93 88.38 -15.34 -36.01 18.08 -21.20 48.91 -272.38 -43.16 -10.20 Cash from Financing Activity -20.89 -24.94 -23.73 -20.80 -6.30 16.83 -75.98 -10.13 -40.25 -43.26 Net Cash Inflow / Outflow -1.27 1.62 18.78 -3.82 -7.50 -16.74 -8.10 48.09 22.85 -33.31 Opening Cash & Equivalents 25.01 21.99 13.13 15.34 15.04 36.95 47.41 0.00 5.09 49.57 Closing Cash & Equivalent 23.59 25.01 21.99 13.13 15.34 15.04 36.95 47.41 27.60 16.26

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 93.68 89.11 81.16 72.31 66.21 58.49 52.49 47.66 41.89 35.65 ROA 4.43% 7.70% 9.15% 7.50% 11.61% 10.41% 8.38% 8.67% 10.48% 10.36% ROE 5.31% 9.66% 11.68% 9.45% 14.36% 13.00% 11.04% 12.80% 16.41% 17.62% ROCE 7.36% 12.89% 14.68% 12.02% 17.75% 18.80% 15.60% 19.25% 23.43% 23.91% Fixed Asset Turnover 1.52 1.83 2.65 2.25 2.99 4.82 3.63 3.44 2.70 3.06 Receivable days 240.71 246.41 217.24 295.44 308.46 267.22 319.34 255.29 257.00 228.48 Inventory Days 49.31 50.10 49.84 56.55 47.66 40.49 41.51 26.05 24.78 25.36 Payable days 79.43 92.78 80.11 88.42 48.84 39.16 90.96 75.73 75.81 99.92 Cash Conversion Cycle 210.59 203.74 186.97 263.57 307.29 268.56 269.89 205.62 205.97 153.91 Total Debt/Equity 0.07 0.08 0.10 0.12 0.13 0.12 0.17 0.15 0.19 0.24 Interest Cover 13.10 12.50 30.23 16.40 19.38 39.08 13.49 11.46 8.41 9.14

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 91.65 84.01 78.01 77.41 71.32 62.63 51.99 47.18 40.00 32.64 ROA 6.89% 6.78% 2.12% 7.03% 9.86% 14.35% 9.42% 11.88% 13.04% 9.01% ROE 8.89% 9.11% 2.88% 9.64% 13.79% 21.43% 17.34% 25.06% 26.73% 19.74% ROCE 12.15% 12.22% 6.37% 12.49% 17.02% 26.58% 24.61% 31.06% 32.07% 23.57% Fixed Asset Turnover 1.66 1.87 2.38 2.06 3.09 5.49 3.37 2.56 1.85 1.47 Receivable days 187.07 188.89 209.14 319.89 267.05 154.20 123.80 126.33 182.13 206.07 Inventory Days 52.48 55.12 54.42 54.72 40.11 27.70 24.25 20.01 24.04 29.51 Payable days 70.38 81.40 77.87 90.85 56.62 35.01 51.74 67.63 95.25 108.77 Cash Conversion Cycle 169.17 162.62 185.69 283.75 250.53 146.89 96.31 78.70 110.92 126.81 Total Debt/Equity 0.09 0.11 0.13 0.15 0.16 0.16 0.22 0.46 0.32 0.47 Interest Cover 17.91 11.23 12.42 15.38 18.04 42.21 7.37 9.91 8.96 6.85

Top Investors:

arian investment limited

life insurance corporation of india

gulbarga trading and investment private

arjun gautam ashra .

gautam rasiklal ashra

investor education and protection fund authority ministry of corporate affairs

coeus global opportunities fund

Annual Reports:

News Update:

Bliss GVS Pharma - Quarterly Results
25th Oct 2024, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback